Tema

Diabetes

Type 1 and type 2 diabetes, insulin resistance, glucose metabolism, and metabolic health

268 artigos

D-Mannose Supplement Reverses Type 2 Diabetes by Blocking Harmful Cell Signals
Metabolic Health

D-Mannose Supplement Reverses Type 2 Diabetes by Blocking Harmful Cell Signals

Simple sugar supplement dramatically improved diabetes symptoms in mice by stopping inflammatory cells from releasing disease-causing particles.

Artigo Científico
10 de abr. de 2026 0
Maternal Blood Sugar and Fat Levels Predict Baby's Birth Weight Risk
Metabolic Health

Maternal Blood Sugar and Fat Levels Predict Baby's Birth Weight Risk

Study of 8,446 pregnancies reveals how maternal glucose and triglyceride levels affect fetal growth patterns.

Artigo Científico
10 de abr. de 2026 0
Body Shape Plus Blood Sugar Index Predicts Fatty Liver Disease Better Than BMI
Metabolic Health

Body Shape Plus Blood Sugar Index Predicts Fatty Liver Disease Better Than BMI

New study shows combining body roundness index with triglyceride-glucose index achieves 80% accuracy in predicting fatty liver disease.

Artigo Científico
10 de abr. de 2026 0
TyG Index Plus Obesity Measures Better Predict Heart Disease Risk Over Time
Metabolic Health

TyG Index Plus Obesity Measures Better Predict Heart Disease Risk Over Time

8-year study of 3,505 Chinese adults shows combining triglyceride-glucose index with waist circumference best predicts cardiovascular disease.

Artigo Científico
9 de abr. de 2026 0
Higher Insulin Sensitivity Linked to 30% Lower Death Risk in Fatty Liver Disease
Metabolic Health

Higher Insulin Sensitivity Linked to 30% Lower Death Risk in Fatty Liver Disease

Large study of 6,847 patients shows better glucose disposal rates significantly reduce mortality risk in metabolic liver disease.

Artigo Científico
9 de abr. de 2026 0
Blood Sugar Stress Ratio Predicts Chronic Disease Risk in Middle-Aged Adults
Metabolic Health

Blood Sugar Stress Ratio Predicts Chronic Disease Risk in Middle-Aged Adults

New biomarker identifies who's at highest risk for diabetes, hypertension, and liver disease using simple blood test calculations.

Artigo Científico
9 de abr. de 2026 0
SGLT2 Inhibitor Dapagliflozin Reshapes Metabolism Beyond Blood Sugar Control
Metabolic Health

SGLT2 Inhibitor Dapagliflozin Reshapes Metabolism Beyond Blood Sugar Control

New study reveals how the diabetes drug dapagliflozin dramatically alters fat metabolism and kidney function through previously unknown pathways.

Artigo Científico
9 de abr. de 2026 0
Melatonin Reverses Metabolic Damage in IVF Children by Fixing Liver Enzymes
Metabolic Health

Melatonin Reverses Metabolic Damage in IVF Children by Fixing Liver Enzymes

New research shows melatonin supplementation during IVF can prevent obesity and glucose problems in offspring by restoring liver function.

Artigo Científico
9 de abr. de 2026 0
GLP-1 Drugs Transform Diabetes Treatment with Weight Loss and Heart Benefits
Metabolic Health

GLP-1 Drugs Transform Diabetes Treatment with Weight Loss and Heart Benefits

Review explores how GLP-1 receptor agonists revolutionize type 2 diabetes care through improved blood sugar control and significant weight reduction.

Artigo Científico
9 de abr. de 2026 0
New Weight Loss Drug Mazdutide Shows 14% Weight Reduction in Chinese Adults
Metabolic Health

New Weight Loss Drug Mazdutide Shows 14% Weight Reduction in Chinese Adults

Phase 3 trial shows once-weekly mazdutide injections led to significant weight loss with minimal side effects in overweight Chinese adults.

Artigo Científico
9 de abr. de 2026 0
GLP-1 Receptor Agonists Show Promise for Longevity and Metabolic Health
Metabolic Health

GLP-1 Receptor Agonists Show Promise for Longevity and Metabolic Health

New England Journal review explores the expanding therapeutic potential of GLP-1 drugs beyond diabetes treatment.

Artigo Científico
9 de abr. de 2026 0
Bariatric Surgery Beats GLP-1 Drugs for Weight Loss and Saves $11,689 Over 2 Years
Metabolic Health

Bariatric Surgery Beats GLP-1 Drugs for Weight Loss and Saves $11,689 Over 2 Years

Major study of 30,458 patients finds surgery achieves 28% weight loss vs 10% with GLP-1 drugs, while costing significantly less long-term.

Artigo Científico
8 de abr. de 2026 0
PreviousPage 9 of 23Next